Comparison of Phenotypic Drug Susceptibility Testing and GeneXpert for the Detection of Mycobacterium tuberculosis against Rifampicin Susceptibility Assay in the South Punjab
Keywords:
Mycobacterium tuberculosis, Phenotypic LJ-DST, Rifampicin, GeneXpert.Abstract
Background: This study aims to compare performance of conventional phenotypic Löwenstein–Jensen (LJ) -drug susceptibility testing (DST) and GeneXpert for the detection of Mycobacterium tuberculosis against Rifampicin (RIF) susceptibility assay from smear positive TB patients in the South Punjab region.
Methods: A total of4809 sputum samples were collected from 16 districts of South Punjab consecutively of newly enrolled and already diagnosed pulmonary TB patients. RIF susceptibility was performed by Phenotypic drug susceptibility testing in parallel with GeneXpert at Provincial TB Reference Laboratory (PRL) in collaboration with Pathology Department, Nishtar Medical College (NMC), Multan.
Results: The final analysis was performed among 4544 (96.68%) cases from enrolled 4809 cases which include 3805 (83.74%) new and 739 (16.26%) on treatment patients. Among them, 4222 (92.91%) cases were susceptible (RIF) while 322 (7.09%) were resistant to Rifampicin. The valid RIF susceptibility testing result was available from substantially more cases with GeneXpert 4400 (96.83%)than with phenotypic DST 4273 (94.04%). Discordant 40 results included 21(0.51%) MTB+RIF ‘S’ on phenotypic LJ-DST and ‘R’ on GeneXpert and 19(0.46%) MTB+RIF ‘R’ on phenotypic LJ-DST and ‘S’ on GeneXpert. This difference (0.97%) was less significant.
Conclusions: This study concluded that the GeneXpert assay had 98.9% specificity in detecting susceptibility to Rifampicin in TB patients. The use of this assay is a feasible option for treating and controlling the tuberculosis in this regional settings.
Downloads
Published
How to Cite
Issue
Section
License
The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.